7. Stockholders' Equity | 7. STOCKHOLDERS EQUITY Private Placement Offerings - Unit Private Placements 2016 Activity On April 6, 2016 and June 13, 2016, the Company completed the first and second tranches of an offer and sale of 100 shares of Series D Preferred stock, resulting in net proceeds of $100,000 to the Company. These shares were issued from the designated 10,000,000 share of Preferred Stock, par value as the Board may determine. In connection with the issuance of the Series D Preferred Stock, the Company issued a total of 3,333,333, five-year Class R warrants to purchase shares of the Companys common stock. The Class R warrants have an exercise price of $0.045 per share of the Companys common stock and had a relative fair value of $47,258, as determined using a Black Scholes model and allocation between the preferred shares and the warrants. The fair value of the warrants was estimated on the issue date using the following weighted average assumptions: April 6, 2016 June 13, 2016 Risk-free interest rate 1.2% 1.14% Expected dividend yield 0 0 Expected term (in years) 5 5 Expected volatility 147.2% 149.6% Additionally, a beneficial conversion feature of $52,742 was determined to exist, which represented a deemed dividend to the holders of the preferred shares recognizable immediately upon issue due to the ability to convert the shares concurrent with issuance of the preferred shares. Both the fair value of the warrants and the beneficial conversion feature were charged to additional paid in capital at the date of issuance. Subsequent to the quarter end, the Company completed the third and final tranche of 50 shares of Preferred D stock, with attached warrants, resulting in net proceeds of $50,000 to the Company (See Note 9, Subsequent Events 2015 Activity On December 7, 2015, the Company completed the offer and sale of 250 shares of Series C Preferred stock, resulting in net proceeds of $225,000 to the Company. These shares were issued from the designated 10,000,000 share of Preferred Stock, par value as the Board may determine. In connection with the issuance of the Series C Preferred Stock, the Company issued a total of 9,166,666, five-year Class Q warrants to purchase shares of the Companys common stock, including 833,333 broker warrants. The Class Q warrants have an exercise price of $0.03 per share of the Companys common stock and had a relative fair value of $116,162 as determined using a Black Scholes model and allocation between the preferred shares and the warrants. The fair value of the warrants was estimated on the issue date using the following weighted average assumptions: Risk-free interest rate 1.68% Expected dividend yield 0 Expected term (in years) 5 Expected volatility 141.9% Additionally, a beneficial conversion feature of $81,250 was determined to exist, which represented a deemed dividend to the holder of the preferred shares recognizable immediately upon issue due to the ability to convert the shares concurrent with issuance of the preferred shares. Both the fair value of the warrants and the beneficial conversion feature were charged to Additional paid in capital at the date of issuance. On April 7, 2015, the Company completed a private placement consisting of 5,000,000 units issued at a price of $0.05 per unit and resulted in net proceeds of $241,832. Each unit consisted of one share of the Companys common stock and one full share Class O warrant. Each full Class O warrant is exercisable to purchase one additional common share of the Company at $0.06, for a period of five years following the date of issue. Warrants During the six-month period ended June 30, 2016, 5,125,936 class H warrants expired, 5,125,935 class I warrants expired, and 3,333,333 class R warrants were issued. At June 30, 2016, there were 59,667,525 common stock warrants outstanding with a weighted average exercise price of $0.156 and a weighted average remaining term of 3.39 years. Stock Options and Stock-Based Compensation: A summary of stock option transactions for the period ended June 30, 2016 are as follows: Shares Weighted- Average Exercise Price (per share) Weighted Average Remaining Contractual Term (Years) Aggregate Intrinsic Value Options outstanding at December 31, 2015 3,350,000 $ 0.24 3.81 $0 Granted - - Expired (150,000) 0.52 Options outstanding and exercisable at June 30, 2016 3,200,000 $ 0.22 3.73 $0 Options available for future grants 2,075,672 For the periods ended June 30, 2016 and 2015, the Company recognized total share-based compensation for employees and consulting directors of $nil. |